Elaine Herrmann Blais

Elaine Herrmann Blais

Goodwin

Contact
View Bio
RSS

Latest Posts › AbbVie

Share:

Coherus and AbbVie File Dueling Motions for Injunctive Relief Relating to Coherus’s HUMIRA Biosimilar

​​​​​​​Our readers may recall that nine HUMIRA biosimilars have been licensed to launch in July 2023, with Amgen’s AMJEVITA the only one to launch to date....more

6/27/2023  /  AbbVie , Biosimilars , Coherus , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide